Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01781845 · ClinicalTrials.gov registry record · NA
Hydronephrosis ARFI Study
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01781845 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 41 participants.
The verdict
NCT01781845, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Pediatric upper urinary tract dilatation (hydronephrosis) is relatively common and may be either obstructive or nonobstructive. While the upper urinary tract is commonly evaluated by ultrasound, this imaging technique often fails to distinguish obstructed from nonobstructed systems. ARFI SVI is a new ultrasound technology that can be used to determine stiffness by measuring a tissue's shear wave velocity, may show alterations in parenchymal shear wave velocity in kidneys that show obstruction on DRS (Diuretic renal scintigraphy)which serves as the reference standard.
Interventions
- PROCEDURE AFRI-SVI Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01781845
The ClinicalTrials.gov registry entry for NCT01781845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AFRI-SVI Ultrasound is the first listed.
NCT01781845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01781845 about?
NCT01781845 is a clinical study titled "Hydronephrosis ARFI Study". Pediatric upper urinary tract dilatation (hydronephrosis) is relatively common and may be either obstructive or nonobstructive. While the upper urinary tract is commonly evaluated by ultrasound, this imaging technique often fails to distinguish obstructed from nonobstructed systems. ARFI SVI is a ne...
What is the current status of trial NCT01781845?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-11. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01781845?
The interventions under investigation include: AFRI-SVI Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT01781845?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.